Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33645231)

  • 1. Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme.
    Checa-Chavarria E; Rivero-Buceta E; Sanchez Martos MA; Martinez Navarrete G; Soto-Sánchez C; Botella P; Fernández E
    Mol Pharm; 2021 Apr; 18(4):1558-1572. PubMed ID: 33645231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells.
    Su H; Zhang P; Cheetham AG; Koo JM; Lin R; Masood A; Schiapparelli P; Quiñones-Hinojosa A; Cui H
    Theranostics; 2016; 6(7):1065-74. PubMed ID: 27217839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a novel sialic acid-conjugated camptothecin prodrug for enhanced cancer chemotherapy.
    Dong H; Huang X; Wu X
    Biomater Sci; 2023 Sep; 11(18):6160-6166. PubMed ID: 37548235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro anti-cancer synergy of neurokinin-1 receptor antagonist, aprepitant, and 5-aminolevulinic acid in glioblastoma.
    Ebrahimi S; Mirzavi F; Hashemy SI; Khaleghi Ghadiri M; Stummer W; Gorji A
    Biofactors; 2023; 49(4):900-911. PubMed ID: 37092793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-Clinical Drug Testing in 2D and 3D Human In Vitro Models of Glioblastoma Incorporating Non-Neoplastic Astrocytes: Tunneling Nano Tubules and Mitochondrial Transfer Modulates Cell Behavior and Therapeutic Respons.
    Civita P; M Leite D; Pilkington GJ
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 phosphorylation inhibitor Bt354 exhibits anti-neoplastic activity in glioblastoma multiforme cells.
    Chiang YC; Selvam P; Liu YX; Shih PC; Chen NF; Kuo HM; Lin HY; Wen ZH; Chen WF
    Environ Toxicol; 2024 Jun; 39(6):3292-3303. PubMed ID: 38415901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy.
    Singh T; Kim TW; Murthy ASN; Paul M; Sepay N; Jeong Kong H; Sung Ryu J; Rim Koo N; Yoon S; Song KH; Jun Baek M; Jeon S; Im J
    Eur J Med Chem; 2024 Feb; 265():116050. PubMed ID: 38128233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identify a Blood-Brain Barrier Penetrating Drug-TNB using Zebrafish Orthotopic Glioblastoma Xenograft Model.
    Zeng A; Ye T; Cao D; Huang X; Yang Y; Chen X; Xie Y; Yao S; Zhao C
    Sci Rep; 2017 Oct; 7(1):14372. PubMed ID: 29085081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel GSH-responsive prodrugs derived from indole-chalcone and camptothecin trigger apoptosis and autophagy in colon cancer.
    Wang H; Nie C; Luo M; Bai Q; Yao Z; Lv H; Chen B; Wang J; Xu W; Wang S; Chen X
    Bioorg Chem; 2024 Feb; 143():107056. PubMed ID: 38183685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavagline synthetic derivative induces senescence in glioblastoma cancer cells without being toxic to healthy astrocytes.
    Harmouch E; Seitlinger J; Chaddad H; Ubeaud-Sequier G; Barths J; Saidu S; Désaubry L; Grandemange S; Massfelder T; Fuhrmann G; Fioretti F; Dontenwill M; Benkirane-Jessel N; Idoux-Gillet Y
    Sci Rep; 2020 Aug; 10(1):13750. PubMed ID: 32792639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyprodrug nanomedicine for chemiexcitation-triggered self-augmented cancer chemotherapy and gas therapy.
    Wang Q; Zhang C; Zhao Y; Jin Y; Zhou S; Qin J; Zhang W; Hu Y; Chen X; Yang K
    Biomaterials; 2024 Sep; 309():122606. PubMed ID: 38776593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of cytotoxic antiproliferative and antiapoptotic effects of nanosized boron phosphate filled sodium alginate composite on glioblastoma cancer cells.
    Poyraz FS; Ugraskan V; Mansuroglu B; Yazici O
    Mol Biol Rep; 2023 Dec; 50(12):10257-10270. PubMed ID: 37934369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diosmin Inhibits Glioblastoma Growth through Inhibition of Autophagic Flux.
    Chang YL; Li YF; Chou CH; Huang LC; Wu YP; Kao Y; Tsai CK
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Camptothecin-based prodrug nanomedicines for cancer therapy.
    Zhang R; Yu J; Guo Z; Jiang H; Wang C
    Nanoscale; 2023 Nov; 15(44):17658-17697. PubMed ID: 37909755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Methanol Extracts of Hyssopus officinalis on Model of Induced Glioblastoma Multiforme (GBM) in Rats.
    Khaksar S; Kiarostami K; Alinaghi S
    J Mol Neurosci; 2022 Sep; 72(9):2045-2066. PubMed ID: 35963984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tricyclic Antidepressants Modulate Stressed Mitochondria in Glioblastoma Multiforme Cells.
    Bielecka-Wajdman AM; Ludyga T; Machnik G; Gołyszny M; Obuchowicz E
    Cancer Control; 2018; 25(1):1073274818798594. PubMed ID: 30213208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological activity assay of novel camptothecin-peptidic conjugates based on PEPT1.
    Zhang Q; Zou P; Zhu M; Sui D; Wang S; Hu Z; Wang Y; Jing L; Zheng J
    Bioorg Med Chem Lett; 2023 Nov; 96():129502. PubMed ID: 37806498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-Dose Compound Heat Map for 3D-Cultured Glioblastoma Multiforme Cells in a Micropillar and Microwell Chip Platform.
    Lee DW; Lee SY; Doh I; Ryu GH; Nam DH
    Biomed Res Int; 2017; 2017():7218707. PubMed ID: 29270434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment.
    Vagaggini C; Petroni D; D'Agostino I; Poggialini F; Cavallini C; Cianciusi A; Salis A; D'Antona L; Francesconi V; Manetti F; Damonte G; Musumeci F; Menichetti L; Dreassi E; Carbone A; Schenone S
    Drug Dev Res; 2024 Feb; 85(1):e22158. PubMed ID: 38349262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors.
    Gigliotti CL; Ferrara B; Occhipinti S; Boggio E; Barrera G; Pizzimenti S; Giovarelli M; Fantozzi R; Chiocchetti A; Argenziano M; Clemente N; Trotta F; Marchiò C; Annaratone L; Boldorini R; Dianzani U; Cavalli R; Dianzani C
    Drug Deliv; 2017 Nov; 24(1):670-680. PubMed ID: 28368209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.